AlphaMaven AlphaMaven

Permira’s Stefan Dziarski on growing fraud intelligence biz BioCatch in the age of AI; Veritas only pursuer of Bodycote after CVC drops out race

Reported by Pehub
Sep 28, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Permira is scaling BioCatch, a fraud intelligence platform, positioning the business to capitalize on heightened cybersecurity demand driven by AI-enabled criminal capabilities and evolving threat landscapes.
  • • Stefan Dziarski, leading Permira's investment in BioCatch, is navigating the dual challenge of leveraging AI for fraud detection while addressing the amplified risks that AI poses to security infrastructure.
  • • Veritas Capital remains the sole active bidder for Bodycote following CVC Capital Partners' exit from the auction process, potentially narrowing the competitive dynamics for the industrial testing and materials services company.
  • • The cybersecurity and fraud prevention sector is experiencing renewed institutional focus as artificial intelligence raises both the sophistication of threats and the capability of defensive solutions.
Summary
Permira is accelerating growth at BioCatch, its fraud intelligence and behavioral analytics platform, amid a period of heightened focus on cybersecurity vulnerabilities intensified by advances in artificial intelligence. Stefan Dziarski, overseeing the investment for Permira, highlighted the paradoxical nature of the current threat environment: while AI capabilities enhance fraud detection and prevention mechanisms, the same technology simultaneously empowers sophisticated criminal actors to evolve their tactics more rapidly than traditional defenses can respond.

The fraud prevention and cybersecurity markets have become priority sectors for private equity investors, reflecting both the scale of emerging threats and the substantial capital requirements needed to build defensible platforms. BioCatch's positioning within this landscape centers on behavioral intelligence—analyzing patterns and anomalies in user activity to identify fraudulent transactions and compromise attempts before they reach critical infrastructure or financial institutions.

In parallel developments within the broader alternative investment landscape, the auction process for Bodycote, the industrial testing, inspection, and materials services company, has consolidated around a single bidder. Veritas Capital is now the only remaining active pursuer of the asset after CVC Capital Partners withdrew from the sale process. This reduction in competitive tension may influence final valuation and deal structure, though Veritas's continued pursuit suggests confidence in the asset's strategic or operational potential despite market conditions.

These transactions underscore institutional investors' sustained appetite for cybersecurity, fraud prevention, and industrial services assets, even as economic uncertainty persists. The sector dynamics reflect structural demand—regulatory requirements, compliance obligations, and genuine threat evolution continue to drive capital deployment regardless of broader market sentiment.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Pehub Permira’s Stefan Dziarski on growing fraud intelligence biz BioCatch in the age of AI; Veritas only pursuer of Bodycote after CVC drops out race